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ABSTRACT
Motivation: Protein–protein interactions (PPIs) are a promising, but
challenging target for pharmaceutical intervention. One approach
for addressing these difﬁcult targets is the rational design of small-
molecule inhibitors that mimic the chemical and physical properties
of small clusters of key residues at the protein–protein interface.
The identiﬁcation of appropriate clusters of interface residues
provides starting points for inhibitor design and supports an overall
assessment of the susceptibility of PPIs to small-molecule inhibition.
Results: We extract Small-Molecule Inhibitor Starting Points
(SMISPs) from protein-ligand and protein–protein complexes in
the Protein Data Bank (PDB). These SMISPs are used to train
two distinct classiﬁers, a support vector machine and an easy to
interpret exhaustive rule classiﬁer. Both classiﬁers achieve better than
70% leave-one-complex-out cross-validation accuracy and correctly
predict SMISPs of known PPI inhibitors not in the training set. A PDB-
wide analysis suggests that nearly half of all PPIs may be susceptible
to small-molecule inhibition.
Availability: http://pocketquery.csb.pitt.edu.
Contact: dkoes@pitt.edu
Supplementary information: Supplementary data are available at
Bioinformatics online.
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1 INTRODUCTION
Protein–protein interactions (PPIs) play a key role in nearly every
biological function and are a promising new class of biological
targets for therapeutic intervention (Dömling, 2008; Wells and
McClendon, 2007). PPIs present a number of unique challenges
compared to targets that have historically dominated pharmaceutical
efforts, such as enzymes, G-protein-coupled receptors, and ion-
channels (Paolini et al., 2006). Unlike these targets, which have
evolved to bind small molecules, PPIs have no convenient natural
substrate to serve as a starting point for small-molecule design.
However, alanine scanning mutagenesis reveals that most of the
energy of a PPI is contributed by just a few ‘hot spot’ residues
(Clackson and Wells, 1995; Moreira et al., 2007; Rajamani et al.,
2004). A small cluster of co-located interface residues that includes
at least one hot spot provides a starting point for the rational design
of small molecule inhibitors (Meireles et al., 2010). Indeed, the
chemical mimicry of small clusters of key residues, typically deeply
buried ‘anchor’ residues (Rajamani et al., 2004), has produced
∗To whom correspondence should be addressed.
inhibitors for several PPI targets (Christ et al., 2010; Liu et al.,
2007; Popowicz et al., 2011).
The importance of hot spot residues and the difﬁculty in
performingalaninescanningmutagenesishasledtothedevelopment
of several computational methods for predicting hot spots. Energy-
based methods (Camacho and Zhang, 2005; Kortemme et al., 2004)
attempt to directly compute the energetic contributions of residues.
Solvent accessible surface area (SASA) (Meireles et al., 2010;
Rajamani et al., 2004) and sequence conservation (Bromberg and
Rost, 2008; Keskin et al., 2005; Lichtarge et al., 1996; Ofran and
Rost, 2007) have also been used to predict hot spots. However, the
most successful computational methods use some combination of
these and other features (Cho et al., 2009; Darnell et al., 2007;
Guney et al., 2008; Lise et al., 2009; Tuncbag et al., 2009; Zhu
and Mitchell, 2011) and achieve accuracies of 60–80%. Often a
consensus scoring mechanism is derived using machine learning
techniques such as decision trees (Darnell et al., 2007) or support
vector machines (Cho et al., 2009; Lise et al., 2009), although ad
hoc consensus schemes are effective as well (Guney et al., 2008;
Tuncbag et al., 2009).
In order to enhance speciﬁcity and afﬁnity, additional interactions
beyond those present in a single individual hot spot residue are
needed. Nearby residues that do not meet the criteria of a hot
spot may also play an important, if not essential, role in the
interaction. Additionally, these residues may describe extra pockets
or energetics essential for small molecule binding or speciﬁcity.
Although identifying a minimum set of stereochemical properties
consistentwithasmall-moleculebindingsiteischallenging(Hajduk
et al., 2005; Pérot et al., 2010), the increasing number of ligand-
protein and protein–protein structures in the Protein Data Bank
(PDB) provides a foundation to explore this important problem with
respect to PPIs. In fact, a systematic analysis of such structures
reveals that residues that participate in both ligand and protein
binding have distinctly different characteristics from other interface
residues (Davis and Sali, 2010). This important insight suggests that
it may be possible to automatically identify those interface residues
that are most susceptible to small-molecule intervention.
In this work we describe a novel structural bioinformatics
approachthatidentiﬁesandranksthoseclustersofinterfaceresidues
in a PPI that are most suitable as starting points for rational small-
molecule design. We refer to these clusters as Small-Molecule
Inhibitor Starting Points (SMISPs). A SMISP is larger than a hot
spot, but substantially smaller than the entire collection of interface
residues. A SMISP cluster may include both those residues critical
to the protein–protein interaction and those with features important
for binding speciﬁcity, all within a volume accessible to a small
molecule.
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SMISPs are complementary to approaches that identify binding
sites through an analysis of the receptor surface (Henrich et al.,
2010), either through shape descriptors (Weisel et al., 2007) or
chemical probes (Brenke et al., 2009; Fuller et al., 2009). However,
a SMISP, as a collection of interface residues, not only deﬁnes a
binding site, it also deﬁnes a binding mode selected by evolution
that provides an initial target for rational small-molecule design.
More general binding site identiﬁcation techniques can then provide
insight on how to extend this natural site or explore the ﬂexibility
of the site.
Previous work has identiﬁed clusters of interface residues from
helical interfaces as small-molecule starting points (Jochim and
Arora, 2010). A manually speciﬁed energy criteria based off of
computational alanine scanning (Kortemme et al., 2004) was
used to identify co-located hot spots on a helix that provided a
signiﬁcant portion of the free energy of the helical interaction.
This method is only partially successful at identifying SMISPs
corresponding to known PPI inhibitors. In addition to being
limited to helical interfaces, we ﬁnd the energy criteria used
to be less informative in characterizing SMISPs than SASA
and alternative energy calculations. Our approach, which uses a
consensus score, is more successful at recovering SMISPs of known
inhibitors.
In a departure from analyses that calibrate to free energies from
alanine scanning experiments, we identify SMISPs directly from
protein–protein and protein-ligand structures. From this structural
analysis we develop a consensus score based on physical and
evolutionary descriptors for predicting and ranking SMISPs. We
develop a methodology for learning two distinct classiﬁers: an
exhaustive rule classiﬁer for ﬁltering SMISPs using an easy to
interpret rule and a support vector machine (SVM) classiﬁer for
ranking SMISPs. Our approach allows us to examine the importance
and role of various factors, such as SASAand free energy estimates,
in deﬁning SMISPs. We demonstrate the ability of our predicted
SMISPs to identify known PPI inhibition sites. Finally, a PDB-wide
analysis predicts the existence of suitable small-molecule inhibitor
starting points in 48% of protein–protein interactions.
2 METHODS
Weusemachinelearningtechniquestolearnbothﬁlteringandscoringcriteria
for identifying SMISPs. Similar approaches have successfully been used to
identify hot spot residues and interface residues (Cho et al., 2009; Darnell
et al., 2007; Lise et al., 2009). For these problems, experimental data, in the
form of alanine scanning experiments and PPI crystal structures, is readily
available. In order to generate a similar benchmark set of SMISPs, we mine
the structural data in the PDB by identifying PPI interface residues that
overlap with known small-molecule binding sites.We annotate all clusters of
interface residues with aggregate indicators of energy, SASA, and sequence
conservation.Thisbenchmarksetisthenusedtotrainbothanexhaustiverule
classiﬁer, which generates an easy to interpret ﬁlter, and an SVM classiﬁer,
which produces a numerical score. The complete workﬂow of our method is
shown in Figure 1.
To support a PDB-wide analysis, we ﬁrst generate a non-redundant subset
of PPI complexes. We use the search feature of the PDB to retrieve all
protein-only structures with at least two chains in the biological assembly
with a resolution of less than 4.0 that have less than 95% sequence similarity
resulting in 13,413 structures (downloaded 6/25/2011). After removing
misclassiﬁed, non-interacting, or otherwise unanalyzable assemblies, 12,456
complexes remain to form our non-redundant set of PPI structures.
Fig. 1. The complete workﬂow of our method. A benchmark of small
molecule inhibitor starting points (SMISPs) is extracted from the structural
information of protein–protein and protein-ligand complexes in the PDB.
Atraining set is generated from this benchmark and used to train both a rule-
based and SVM classifer which then back-annotate an entire non-redundant
subset of PPI complexes from the PDB.
2.1 Benchmark set
Protein–protein interactions remain a challenging and relatively untargeted
area of pharmaceutical intervention resulting in a scarcity of proven small-
molecule starting points. However, an analysis of the structures deposited in
the PDB reveals that for many PPIs there exists a structure where at least
one chain of the PPI is complexed with a small molecule that binds at the
PPI interface site. A sufﬁciently high-afﬁnity small-molecule targeting such
a site will, at the very least, perturb the interaction. Consequently, we utilize
such ligand-bound structures to identify benchmark SMISPs in the original
PPI.AbenchmarkSMISPisthecollectionofallinterfaceresiduesfromaPPI
structure that overlap a high-afﬁnity ligand from a protein-ligand structure
aligned to the PPI structure.Abenchmark SMISPat least partially delineates
the binding site of the ligand, thus providing a validated starting point for
the design of a small-molecule inhibitor.
For each chain of each complex in our non-redundant set, we identify all
structures in the PDB that have 95% or greater sequence similarity to this
receptor chain and that are bound to a standalone ligand (i.e., not a modiﬁed
residue). We consider only ligands with a molecular weight greater than 150
Da to eliminate non-speciﬁc interactions such as ions and crystallographic
buffers.Wethenaligntheligand-boundstructuretotheoriginalPPIcomplex.
The collection of at least two PPI interface residues that contain atoms that
overlap the atoms of the ligand in the ligand-bound structure in this aligned
assembly is marked as a SMISP. Atom centers must be less than 2.5Å apart
for atoms of the ligand and a residue to be considered overlapping (i.e., less
than the distance of a hydrogen bond).
In some cases the ligand-bound structure is not a single chain protein, but
a protein–protein complex that is homologous to the original PPI complex.
In this case we impose an additional constraint that the backbone in the
785[14:36 29/2/2012 Bioinformatics-btr717.tex] Page: 786 784–791
D.R.Koes and C.J.Camacho
(a) (b)
Fig. 2. Example training SMISPs. The PPI is represented by a receptor
protein (yellow surface) and a ligand protein (transparent blue). A small-
molecule inhibitor (green) is posed by aligning the corresponding receptors.
TrainingSMISPs(blue),clustersofinterfaceresiduesthatoverlaptheligand,
identify the binding pocket, but are not required to reproduce the exact
interactions of the ligand. (a) Bcl-xL in complex with the BaxBH3 domain
(PDB: 3PL7) is shown with the sub-nM inhibitor ABT-737 (PDB: 2YXJ).
The LEU-63 residue of the SMISP ﬁlls a deep hydrophobic pocket that is
also ﬁlled by the inhibitor, while ILE-68 ﬁlls a hydrophobic pocket that
closes around the inhibitor in the ligand bound structure. The backbones
of the remaining residues serve to further delineate the inhibitor binding
site. (b) The interleukin-2 cytokine receptor complex (PDB: 2B5I) shown
with an 8μM inhibitor (PDB: 1M48). The positively charged guanidinium
group ofARG-36 overlays a guanidinium on the inhibitor while LEU-42 ﬁlls
a hydrophobic pocket that closes around the inhibitor in the ligand-bound
structure. GLU-29 and ASN-27 delineate a polar region of the receptor that
is only partially targeted by the inhibitor as this region has a signiﬁcantly
different conformation in the ligand-bound structure.
region of the SMISP residues be substantially distorted from the original
PPI backbone (the root mean square deviation should be more than 1Å).
These ligands do not prevent the formation of the protein–protein complex,
since they bind to the fully formed complex, but we include them in the
benchmark set since a signiﬁcant perturbation of the interface structure will
likely affect the function of the PPI.
We further reﬁne our collection of SMISPs derived from structure by
incorporating binding afﬁnity data from the PDBbind (Wang et al., 2005),
BindingDB (Liu et al., 2006), and Binding MOAD (Hu et al., 2005)
databases.We restrict our benchmark SMISPs to only those where the ligand
bound structure (or a homologue with at least 95% sequence identity) has
an afﬁnity of 100μM or better to exclude spurious or low-afﬁnity ligand-
proteininteractions.TheresultingcollectionofSMISPsincludes135distinct
SMISPs derived from 267 ligands targeting 51 PPI complexes. There are
nearlytwiceasmanyligandsasSMISPssinceinmostcasesligandstargeting
the same protein deﬁne identical or nearly identical SMISPs. Two SMISPs
from this set, both derived from known PPI inhibitors, are shown in Figure 2.
The SMISPs sterically delineate part of the binding site of the ligand in the
unliganded complex. SMISPs cannot identify binding pockets that require a
conformational change of the receptor complex, such as in Figure 2b where
the ligand partially binds to a groove not present in the PPI structure. Our
complete set of benchmark SMISPs is available in the Supplementary Data.
2.2 Cluster features
We decompose PPI structures into clusters of multiple interface residues
where each cluster will be evaluated for its potential to be a SMISP.
An interface residue is deﬁned as a residue where the change in SASA
upon complexation is more than 0.05Å
2. All SASA calculations are
performed using naccess (http://www.bioinf.manchester.ac.uk/naccess/). To
limit clusters to a volume accessible by small molecules, we consider only
clusters where the centers of mass of any two residues in the cluster are
less than 12Å apart. This distance is roughly equal to two turns of an α-
helix and encompasses a volume larger than the 500Å
3 usually observed in
protein-ligand interactions (An et al., 2005).
For every cluster of interface residues, we generate a collection of
aggregate features for use in SMISP classiﬁcation. For each residue in the
cluster we compute two energy scores,  GFC and   GR, the absolute
( SASA) and the relative ( SASA%) change in solvent accessible surface
area, and two measures of sequence conservation, an evolutionary rate
(Rate) and a conservation score (Cons). These features are aggregated into
the minimum, maximum, average, and total value for each cluster. For all
calculations, we use the ﬁrst biological assembly deposited in the PDB and
preprocess the structure with CHARMM version 31b1 (Brooks et al., 1983).
CHARMMisusedtoaddmissingatoms,includinghydrogens,andtoquickly
minimize the resulting structure to optimize hydrogen bonding.
 GFC FastContact (Camacho and Zhang, 2005) is used to compute a per-
residue estimate of the free energy (kcal/mol) of complexation. It includes
both electrostatic ( GFC
elec) and desolvation (  GFC
dsolv) effects within an
atomistic pair-wise potential. More negative values indicate energetically
favorable residues.
  GR We use version 3.2.1 of the Rosetta software (Kortemme et al., 2004)
to perform computational alanine scanning. The AlaScan ﬁlter is used with
the   G optimized scoring function, an interface distance cutoff of 10Å,
ﬁve repeats, and an initial local reﬁnement docking. This value represents
the change in free energy of the alanine mutation, so a larger, more positive
value indicates that the alanine mutation destabilizes the complex and the
original residue is a hot spot.
 SASAThechangeinabsoluteSASAofaresidueiscalculatedbysubtracting
the SASA of the residue in the PPI complex from the SASA of the residue
whenallotherproteinchainshavebeenremovedfromthePPIstructure.That
is, the bound conformation of the chain of the residue is used to compute the
un-complexed SASA.
 SASA% The change in the relative SASA of a residue. Expressed as a
percentage of accessible surface area.
RateAmultiple sequence alignment (MSA) of related sequences is obtained
by using BLAST (Altschul et al., 1990) to retrieve the 20 most similar
sequences from the UniRef90 database (Wu et al., 2006) and aligning the
results with ClustalW version 2.0 (Larkin et al., 2007). An evolutionary
rate for each residue is computed using Rate4Site version 2.01 (Mayrose
et al., 2004). Rate4Site uses an empirical Bayesian method to compute
an evolutionary rate from a phylogenetic tree it constructs from the MSA.
A higher score indicates a higher rate and lower degree of conservation. If
there are no similar sequences in UniRef90 (for example, when searching
for a short peptide), then no value is generated.
Cons An MSA is generated as above and a conservation score is computed
using Scorecons (Valdar, 2002) with the default parameters. The score is a
function of the sum-of-pairs pairwise match within the MSA, a substitution
matrix, and a sequence weighted normalization. A higher score indicates a
higher degree of conservation.
2.3 Training
We utilize two classiﬁcation methods a support vector machine (SVM)
classiﬁer and an exhaustive rule classiﬁer. We construct a balanced training
set from our benchmark SMISPs, and we use leave-one-complex-out
cross-validation to parameterize the classiﬁers and assess their accuracy.
Training set We construct a training set from the benchmark set that is evenly
distributed among the PPI structures: for each PPI we generate 100 positive
examples and 100 negative examples.
Positive examples are selected by combining the SMISP benchmark set with
the 12Å clusters. Only the largest clusters that are fully contained within
a benchmark SMISP are selected. In most cases, this results in positive
examples that are identical to the benchmark SMISPs, but ﬁve training set
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Table 1. Validation set of PPIs with known inhibitors
Description PPI PDB Ch Lig. PDB #SMISPs #Clust
p53/MDM2 1YCR B 3LBK 100 311
p53/MDM4 3DAB B 3LBJ 45 79
XIAP/Caspase-9 1NW9 B 3CLX 30 537
XIAP/Smac 1G73 A 2JK7 117 1793
HIV gp41 1AIK C 2KP8 66 639
Bcl-xL/Beclin1 2P1L B 2O2N 572 1503
Bcl-2/BaxBH3 2XA0 C 2O22 762 1327
HIV-1 Integrase/p75 2B4J C 3LPT 36 123
ZipA/FtsZ 1F47 A 1Y2F 40 263
HPV E1/E2 1TUE A 1R6N 56 312
TNF- α 1TNF C 2AZ5 80 2979
PPIs were identiﬁed from the literature (Bourgeas et al., 2010; Higueruelo et al., 2009;
Stewart et al., 2010; Wells and McClendon, 2007) and only inhibitors with known
structure that bind at the PPI interface are considered.The number of SMISPs predicted
by our combined classiﬁer is shown with the total number of clusters evaluated. As
clusters are all possible collections of co-located interface residues, the number of
clusters is combinatorially related to the number of interface residues.
PPIs have large benchmark SMISPs that are decomposed into all possible
maximal subsets of residues that ﬁt within a 12Å distance cutoff.
Negative examples are generated by selecting clusters of interface residues
from the same chain(s) as the benchmark SMISPs that are equal in size to the
SMISPs selected as positive examples and in no way overlap any benchmark
SMISPs of the PPI.
Since the number of negative examples is typically much larger than
the number of positive examples and SVMs perform poorly on imbalanced
training data, we re-sample the data to create a balanced training set
(Batuwita and Palade, 2010). For both positive and negative examples,
random selection with replacement is performed. A sample size of 100 was
found to produce stable results across multiple trials of random sampling.
Missing values, which are present for the sequence conservation scores
whennosimilarsequencesarefound,arereplacedbyaveragevalues.Twelve
PPIs in the benchmark set contain no negative examples because the ligand
protein of the PPI is a short peptide where all, or nearly all, of the interface
residues make up a SMISP. Since the entire peptide deﬁnes a SMISP, these
12 PPIs are trivial to identify as SMISPs and are excluded from the training
set. There are a total of 7800 training examples from 39 PPI complexes. The
composition of the training set is further described in the Supplementary
Data.
Leave-one-complex-out validation is performed by removing all training
examples of a PPI complex from the training set and then using these
examples as a test set resulting in 39 unique train-test datasets. The cross-
validation accuracy (correct predictions divided by total predictions) is
computed by taking the average across these datasets.
Validation set In order to qualitatively characterize the performance of our
classiﬁers, we construct a validation set of 11 PPI complexes with known
inhibitors where both the protein–protein and protein-ligand structures are
available.Thesecomplexeswereidentiﬁedfromrecentpublications(Stewart
etal.,2010;WellsandMcClendon,2007)andPPIdatabases(Bourgeasetal.,
2010; Higueruelo et al., 2009) and are shown in Table 1. These complexes
did not appear in the training set because the inhibitor was not present in
the binding afﬁnity databases or a sufﬁciently homologous complex was
not available in the non-redundant subset. We do not consider three PPIs
(PDBs: 1DT7, 1TNR, 2NOD) with known inhibitors and structure where the
inhibitor binding site does not overlap the PPI interface. These inhibitors are
presumed to function allosterically and are beyond the scope of our SMISP
classiﬁcation. The only overlap between this validation set and the training
set is with the Bcl-xL/BaxBH3 complex of Figure 2b. The validation set
includes a Bcl-xL/Beclin 1 complex and a Bcl-2/BaxBH3 complex.
SVM classiﬁer We train our SVM classiﬁer using the recommended
procedure for libSVM (see Supplementary Data). The pairwise coupling
method (Wu et al., 2004) is used to generate probability estimates for scoring
potential SMISPs.The best cross-validation accuracy (74%) is obtained with
a score threshold of 0.55. Higher score thresholds increase the speciﬁcity,
but at the cost of substantially reduced recall. The average of the areas under
the cross-validation receiver operating characteristic (ROC) curves is 0.82.
Complete performance metrics for a variety of score thresholds are available
in Supplemental Table S1 and the ROC curve is shown in Supplemental
Figure S4.
Exhaustive rule classiﬁer Previous work with hot spot prediction (Tuncbag
et al., 2009) has shown that simple thresholding rules, e.g.  SASA > 60,
can be as effective as more sophisticated classiﬁers. Such rules have the
advantage of being easy to interpret and modify. However, they produce a
strict binary classiﬁcation and cannot be used to score and rank inputs.
Our rule classiﬁer identiﬁes rules that maximize the information gain.The
information gain (IG) of a rule is the expected reduction in Shannon entropy
if the result of applying the rule to the input dataset is known:
IG =
−log2(P)−log2(N)
N+P
−

TP+FP
N+P

−log2(TP)−log2(FP)
TP+FP

−

TN+FN
N+P

−log2(TN)−log2(FN)
TN+FN

where N and P are the number of negative and positive examples andTP, FP,
TN, and FN are the number of true positives, false positives, true negatives
and false negatives after classiﬁcation with the rule. An information gain
of one is only possible if the rule perfectly classiﬁes the dataset, and an
information gain of zero implies the rule is no better than random.
We use an exhaustive rule classiﬁer to generate the conjunctive rule
of a given set of attributes that maximizes the information gain. The
optimal set of thresholds is found through an exhaustive exploration that is
accelerated using branch and bound techniques (Rijnbeek and Kors, 2010).
The advantage of our exhaustive rule classiﬁer is that the thresholds for
different attributes are determined simultaneously and optimally, in contrast
to methods, such as decision trees, that greedily select and set attributes and
thresholds. The C/C++ source code of our implementation is available in the
Supplementary Data.
We cross-validated our classiﬁer using all possible one, two, and three
attribute rules to identify the most accurate and informative attributes. The
addition of a third attribute does not meaningfully improve the performance
of the classiﬁer: the most informative two attribute and three attribute rules
both have a cross validation accuracy of 72%. Since the addition of a third
attribute does not improve performance, we consider no more than two
attributes per rule to avoid over-ﬁtting the data.
3 RESULTS
We analyze the information theoretic properties of our cluster
features to highlight the most useful features for classiﬁcation. We
show that we can recover known PPI inhibitor sites and assess the
general accessibility of PPIs to small-molecule inhibitors.
3.1 Information gain analysis
A selection of cluster features are shown ranked by the information
gain of the corresponding single-attribute rule in Table 2. The single
most informative feature is the average  SASA.Average  SASA%
and  GFC are also informative and have good classiﬁcation
accuracies. These average values, which represent the entire cluster,
are more informative than extrema values of the same criteria
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Fig. 3. SMISPs predictions for some of the PPIs from Table 1. The PPI is represented by a receptor protein (surface) and a ligand protein (transparent
magenta). A small-molecule inhibitor (green) is posed by aligning the corresponding receptors. The single largest SMISP ranked in the top three is shown
as magenta sticks. PDB access codes are provided in Table 1. In Figures (a-f) the predicted SMISPs overlap the inhibitor and at least partially delineate the
binding pocket(s). In Figures (g-h) the SMISPs only marginally overlap the inhibitor and identify a nearby, but distinct, binding pocket. (a) p53/MDM2. (b)
XIAP-BIR3/Caspase-9. (c) HIV gp41. (d) Bcl-xL/Beclin 1. (e) HIV-1 Integrase/p75. (f) ZipA/FtsZ. (g) HPV E1/E2. (h) TNF-α.
Table 2. Single attribute rules.
Info. Gain Rule Accuracy (%)
0.137 Ave  SASA ≥44.6 68 ± 3.6
0.128 Ave  SASA% ≥39.6 68 ± 3.7
0.103 Ave  GFC: <−2.3 67 ± 3.9
0.081 Ave  GFC
dsolv: <−1.64 61 ± 3.4
0.070 Max   GR: ≥0.427 62 ± 3.1
0.042 Min  GFC
elec: <−1.3 61 ± 3.7
0.038 Total Rate4 ≥1.6 52 ± 2.7
0.032 Min Cons <0.086 52 ± 1.5
The optimal single attribute rules for the most informative aggregate statistic of each
of the computed properties are shown ranked by information gain. The information
gain and rule thresholds are computing using the entire training set. The accuracies
are averages across the 39 train-test cross-validation sets and are shown with the
standard error of the mean. The complete list of attributes with additional measures
of performance are shown in Supplementary Table S2.
(maximum surface area or minimum energy) that only represent
the ‘hottest’ residue in the cluster. This underscores the value of
our approach, which analyzes clusters as a unit, as opposed to an
approach that simply identiﬁes co-located hot spots.
Surprisingly,   GR, which has been previously used to identify
small molecule starting points in helical PPIs (Jochim and Arora,
2010), is found to be less informative than the surface area and
 GFC metrics. This metric requires mutating and scoring the
protein complex, and the result does not include the energetics of
the backbone, which may be relevant to small-molecule design.
Interestingly, the maximum   GR, which identiﬁes if a cluster
contains at least one hot spot, is found to be substantially more
informative than the average or total values. This may indicate that
  GR is calibrated to emphasize and isolate individual hot spots.
Table 3. The three most informative two-attribute rules.
Info. Gain Rule Accuracy (%)
0.175 Ave  SASA ≥44.6 72 ± 3.8
Ave  SASA% ≥39.6
0.171 Ave  GFC: <−2.27 71 ± 3.8
Total  SASA% ≥125
0.167 Max   GR: ≥0.425 66 ± 3.8
Ave  SASA ≥46.1
The information gain and rule thresholds are computed using the entire training set.
The accuracies are averages across the 39 train-test cross-validation sets and are shown
with the standard error of the mean. The ten most informative two attribute rules are
shown with additional measures of performance in Supplementary Table S3.
Although interface residues have been found to have a
distinguishable conservation proﬁle (Bordner and Abagyan, 2005),
hot spot prediction using only sequence performs poorly (Ofran and
Rost, 2007; Tuncbag et al., 2009) and residues that participate in
bothligandandproteinbindinghavebeenfoundtobelessconserved
(DavisandSali,2010).Consistentwiththeseresults,weﬁndthatthe
conservation metrics are the least informative and that, on average,
thereisaslightpreferenceforpredictedSMISPstobelessconserved
than the rest of the interface.
Various forms of  SASA are clearly the best indicators of
SMISPs. However, as shown inTable 3, energy metrics complement
surface area metrics when combined in a two-attribute rule. Seven
of the top ten most informative two-attribute rules contain some
combination of energy and surface area terms. The combination
of average  GFC and total  SASA% has a cross validation
accuracyof71%andprovidesgreaterspeciﬁcity,91%,thanthemost
informative surface area only rule. This is similar to rule-based hot
spot prediction (Tuncbag et al., 2009), where a manually derived
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rule consisting of an energy pair-potential and relative SASA had
an accuracy of 70% on an independent test set.
3.2 Validating predicted SMISPs
Eight of the eleven PPIs of our validation set are shown with a
predicted SMISP in Figure 3 and the three remaining complexes,
which are similar, are shown in Supplementary Figure S2. The
SMISPs are ﬁltered using the most informative two-attribute rule
from Table 3 and the 0.55 SVM score threshold. The SMISPs are
then ranked by score. Both classiﬁers are trained on the entire
training set.The number of identiﬁed SMISPs for each PPI is shown
in Table 1 and ranges from 30 to 762. The largest SMISP in the top
three SMISPs is shown in Figure 3 in order to illustrate the diversity
of interactions that are present in a top ranked SMISP (the smaller
top ranked SMISPs are typically subsets of the shown SMISP).
In nine of the complexes shown in Figures 3(a-f) and
Supplementary Figure S2, the SMISPs clearly identify the binding
site and, in many cases, duplicate the hydrophobic and electrostatic
interactions of the small-molecule ligands. In fact, eight of these
nine complexes possess ligands that were designed speciﬁcally to
mimic the residues of the predicted SMISPor to otherwise target the
pocket described by the predicted SMISP and therefore represent a
retrospective validation of the predictions. In two cases, p53/MDM2
andHIVgp41,thepredictedSMISPscontainexperimentallyveriﬁed
hot spot residues (Chan et al., 1998; Lin et al., 1994). The
Supplementary Data elaborates on the properties and signiﬁcance
of these predictions. In addition, all 12 short-peptide PPIs that were
omitted from the training set as trivial classiﬁcations are correctly
identiﬁed (not shown).
In the remaining two complexes the predicted SMISPs have little
ornooverlapwiththeinhibitor.InbothFigures3gandhtheinhibitor
clasheswiththePPIreceptorindicatingthatitbindstoasigniﬁcantly
different receptor conformation. Consequently, signiﬁcant portions
of the small molecule do not overlap any PPI residues, preventing
the identiﬁcation of a SMISP. Of course, the SMISPs that are
predicted may provide an alternative, as yet unexplored, mechanism
of inhibition.
In most cases, our top ranked SMISPs partially or fully delineate
the binding site of a known inhibitor, indicating that SMISPs
provide an immediate and useful computational hypothesis for
the initiation of structure-based design. We provide examples of
predicted SMISPs with potential therapeutic application in the
Supplementary Data. Since our method provides a ranking of
SMISPs, for a speciﬁc PPI we can always identify the most
promising SMISP. A list of the top ﬁve SMISPs predicted for every
chain in our non-redundant dataset is provided in the Supplementary
Data and the complete set is accessible through an online search
interface at http://pocketquery.csb.pitt.edu.
3.3 PDB-Wide analysis
We use our SMISPs classiﬁers trained on the full training set to
analyzeourentiresetofPPIs.TheinterfaceresiduesofthesePPIsare
decomposed into more than 95 million clusters. Since true SMISP
clusters are expected to be relatively rare, we combine the rule
classiﬁer and SVM score threshold with the highest cross-validation
accuracy.Acluster is only classiﬁed as a SMISP if it is predicted by
both classiﬁers. Unsurprisingly, given the cross-validation accuracy
of the classiﬁers, we ﬁnd that 95% of the protein chains in our
Fig. 4. A density plot of the quantity and quality of the predicted
SMISPs of all the complexes in our non-redundant set of PPIs. 95%
of PPIs have at least one predicted SMISP, but signiﬁcantly fewer have a
signiﬁcant quantity of highly ranked SMISPs. PPIs with known structure
and known inhibitors from Figure 2 and Table 1 are shown plotted at their
maximal quantity/quality. These complexes are clearly biased towards the
less populated, high quality, high quantity region of the plot. Of the 13
complexes, 11 are contained within the shaded area deﬁned by a minimum
quantity of 6% and a minimum quality of 0.84. 10,920 chains (40%) and
5,757 PPIs (48%) of the non-redundant PDB subset are contained within
this region. Since these structures share the same quality/quantity proﬁle
as structures with known inhibitors, we predict that they are accessible to
small-molecule inhibitor design.
dataset have at least one predicted SMISP. In order to extend our
predictions of individual SMISPs to an overall assessment of the
susceptibilityofPPIstoinhibitordesign,weevaluatethedistribution
of predicted SMISPs within each PPI. We consider the quantity of
SMISPs(thepercentofinterfaceclustersthatarepredictedSMISPs)
and the quality (the maximum score of the predicted SMISPs).
Figure 4 shows a density plot of the number of PPI chains in
our non-redundant set whose predicted SMISPs fall within given
quantity and quality thresholds. For example, as indicated by the
color plotted at (0%,0.85), there are 14252 chains with at least
one predicted SMISP with a maximum score that is at least 0.85.
PPIs with known inhibitors (from Figures 2 and Table 1) are visibly
enriched in the higher quality, higher quantity region of Figure 4.
A quantity/quality threshold of (≥6%, ≥0.84), shown shaded in
Figure 4, selects 11 of the 13 complexes with known inhibitors. The
remaining two complexes, HPV E1/E2 and TNF-α from Figures 3g
and h, were the two cases where the predicted SMISP failed to
identify the binding site of the inhibitor due to conformational
changes of the protein receptor. Since this is the strictest threshold
that captures all the PPIs where the predicted SMISPs correctly
identify the binding site of the inhibitor, we predict that complexes
within this threshold are likely susceptible to small-molecule
inhibition through the chemical mimicry of a small set of interface
residues. Nearly half, 48%, of all the PPIs in our dataset fall within
this threshold. Of course, this estimate does not include the potential
to design allosteric inhibitors.Additionally, our analysis is based on
existing structures and therefore cannot predict the susceptibility of
PPIs to new mechanisms of inhibition.
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The quality and quantity thresholds computed for each PPI chain
deﬁne a partial order, where one chain is better than another if it has
both a higher score and a greater quantity. We use this partial order
to rank every PPI chain in our dataset and provide this ranking in
the Supplementary Data.
4 DISCUSSION
PPIs are an emerging class of biological targets that have been
poorly addressed by high throughput screening (Macarron, 2006).
The steadily increasing amount of PPI structural information
makes structure-based rational design one attractive alternative.The
interactions of the complex itself provide a natural starting point as
long as the most favorable interactions can be effectively identiﬁed.
Previous work has largely focused on identifying individual
hotspots, i.e. single residues that contribute a signiﬁcant portion of
the free energy of the complex. We have built upon this previous
work to address the problem of ﬁnding an entire set of residues that,
as a unit, identify a binding site that is susceptible to small-molecule
inhibition. Our automated structural bioinformatics method learns
both scoring (SVM-based) and ﬁltering (rule-based) classiﬁers for
identifying these sites.
A novel aspect of our method is that we use the structure of
PPI complexes and known binders at the PPI interface to create
our training set. SMISPs are identiﬁed purely from the steric
overlap of small-molecule binders and the PPI structure.This results
in a less quantitative assessment of training examples compared
to using alanine scanning results. However, our structure-based
approach has several advantages. The existence of a high-afﬁnity
ligand at the protein interface is more relevant to our goal of
identifying small-molecule starting points. Alanine scanning may
identify hot spots for reasons that are not relevant to inhibition,
such as the residue’s contribution to protein stability. Additionally,
the   G does not include any backbone contributions, which
may be important for small molecule design. Our structure-based
method naturally identiﬁes groups of co-located residues, SMISPs,
as opposed to single, potentially isolated hot spot residues. Finally,
our method beneﬁts from the rapidly increasing number of available
protein structures, exempliﬁed by the PDB.
We use a standard SVM classiﬁer for ranking SMISPs, but also
ﬁnd that simple thresholding rules provide an easily interpretable
alternative classiﬁer with accuracy similar to more sophisticated
techniques. Unlike previous work that relied on a subjective
evaluationofhistogramstosetrulethresholds(Tuncbagetal.,2009),
our exhaustive rule classiﬁer uses information theoretic techniques
to automatically identify the optimal classiﬁcation rules from the
training set.
Our approach correctly predicts the binding sites and, to a
lesser extent, the interactions of several known PPI inhibitors.
Perhaps more interestingly, the application of our classiﬁers to a
non-redundant subset of the PDB containing more than 12,000
complexes reveals that nearly half the complexes contain at least
one chain that has a similar distribution of predicted SMISPs as
complexes with known inhibitors. This suggests that PPIs may
be substantially more susceptible to small-molecule inhibition
than indicated by the current distribution of pharmaceutical
targets (Paolini et al., 2006). The historical bias against PPI
targets present in existing compound libraries makes structure-
based rational design a logical paradigm for developing PPI
inhibitors. The SMISPs identiﬁed using our approach and available
from http://pocketquery.csb.pitt.edu provide an
immediate computational hypothesis to initiate such efforts which
have the potential to ultimately culminate in the design of novel
therapeutics.
Funding: National Institute of Health [1R21GM087617,
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